31: Burden of MASH in patients with Type 2 Diabetes Mellitus
27:09
31: Burden of MASH in patients with Type 2 Diabetes Mellitus
29: Molecular Mechanisms underlying Alcohol Abstinence and Relapse in ALD
26:27
29: Molecular Mechanisms underlying Alcohol Abstinence and Relapse in ALD
28: Gut Microbiome in Liver Cancer
30:23
28: Gut Microbiome in Liver Cancer
27: ACG Clinical Guideline for ALD
27:47
27: ACG Clinical Guideline for ALD
27: ACG Clinical Guideline for ALD
27:47
27: ACG Clinical Guideline for ALD
24: Decoding Immunotherapy-Related Liver Injury in Hepatocellular Carcinoma
32:58
24: Decoding Immunotherapy-Related Liver Injury in Hepatocellular Carcinoma
23: Navigating the Landscape of Living Liver Donor Psychosocial Evaluations in the U.S.
27:33
23: Navigating the Landscape of Living Liver Donor Psychosocial Evaluations in the U.S.
22: Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
24:20
22: Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
21: Confronting Obesity and Steatotic Liver Disease Challenges
21:56
21: Confronting Obesity and Steatotic Liver Disease Challenges
19: Latest Advancements in Liver Transplantation
20:20
19: Latest Advancements in Liver Transplantation
20: Blood-based Biomarkers for HCC Surveillance
28:11
20: Blood-based Biomarkers for HCC Surveillance
10: Mastering Cirrhosis Management - BSG Best Practice Guidance
33:39
10: Mastering Cirrhosis Management - BSG Best Practice Guidance
17: Prevalence, Mortality, and Biomarkers of Acute Kidney Injury in Severe Alcohol-Related Hepatitis
29:44
17: Prevalence, Mortality, and Biomarkers of Acute Kidney Injury in Severe Alcohol-Related Hepatitis
16: The Sobering Truth - The Rising Costs of Alcohol-Associated Liver Disease in the United States
17:28
16: The Sobering Truth - The Rising Costs of Alcohol-Associated Liver Disease in the United States
14: Fueling Your Health - Diet’s Role in Taming Non-Alcoholic Fatty Liver Disease
23:48
14: Fueling Your Health - Diet’s Role in Taming Non-Alcoholic Fatty Liver Disease
18: A Nurse Practitioner’s Insights on Alcohol-Associated Liver Disease
24:25
18: A Nurse Practitioner’s Insights on Alcohol-Associated Liver Disease
15: How Accurate is Diagnostic Imaging in Compensated Cirrhosis?
20:59
15: How Accurate is Diagnostic Imaging in Compensated Cirrhosis?
13: Global Disparities in Cirrhosis Mortality and Liver Transplantation - CLEARED Consortium
25:03
13: Global Disparities in Cirrhosis Mortality and Liver Transplantation - CLEARED Consortium
12: Global Public Health Agenda for Steatotic Liver Disease - Expert Insights into MASLD
23:52
12: Global Public Health Agenda for Steatotic Liver Disease - Expert Insights into MASLD
11: Cost Barriers of Rifaxamin in Hepatic Encephalopathy Treatment
24:10
11: Cost Barriers of Rifaxamin in Hepatic Encephalopathy Treatment
09: Liver Transplantation in NASH Cirrhosis
24:13
09: Liver Transplantation in NASH Cirrhosis
08: Medications and Liver Health in Alcohol Use Disorder
26:33
08: Medications and Liver Health in Alcohol Use Disorder
07: Breaking Down the Silent Threat of Nash-Related Cirrhosis
22:34
07: Breaking Down the Silent Threat of Nash-Related Cirrhosis
06: Liver Disease and Healthcare in Veterans
28:39
06: Liver Disease and Healthcare in Veterans
05: Bariatric Endoscopy’s Impact on Chronic Liver Disease
23:25
05: Bariatric Endoscopy’s Impact on Chronic Liver Disease
03: Fatty Liver to Deadly Tumor: Surveillance of NAFLD-HCC
15:12
03: Fatty Liver to Deadly Tumor: Surveillance of NAFLD-HCC
02: Getting #Match for GI Fellowship
24:06
02: Getting #Match for GI Fellowship
04: Confronting Alcohol Withdrawal in Alcohol-associated Hepatitis
40:19
04: Confronting Alcohol Withdrawal in Alcohol-associated Hepatitis
01: MASLD - The New NAFLD Nomenclature?
19:17
01: MASLD - The New NAFLD Nomenclature?